Citation Impact
Citing Papers
Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase
2007 StandoutNobel
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension
2016
The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease
2004
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
2008
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
2005 Standout
Resistant Hypertension
2008
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
2007 Standout
From Left Ventricular Hypertrophy to Congestive Heart Failure: Management of Hypertensive Heart Disease
2006
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism
2012
Cardiac dysfunction in patients with cirrhosis
2015
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Aldosterone Stimulates Reactive Oxygen Species Production through Activation of NADPH Oxidase in Rat Mesangial Cells
2005
Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside
2016
Efficacy of low-dose spironolactone in subjects with resistant hypertension
2003
Management of Glomerular Proteinuria
2003
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity
2016
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism
2011
Evidence for renoprotection by blockade of the renin–angiotensin–aldosterone system in hypertension and diabetes
2006
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Management of High Blood Pressure in African Americans<subtitle>Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks</subtitle>
2003
Hibiscus sabdariffa L. – A phytochemical and pharmacological review
2014 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Clinical Presentation, Management, and In-Hospital Outcomes of Patients Admitted With Acute Decompensated Heart Failure With Preserved Systolic Function
2005
Chronic kidney disease
2011 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Update of Diuretics in the Treatment of Hypertension
2007
Improving the efficacy of RAAS blockade in patients with chronic kidney disease
2012
Low‐Dose Aldosterone Blockade as a New Treatment Paradigm for Controlling Resistant Hypertension
2007
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism
2008
Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus
2006
The Efficacy and Safety of the Novel Aldosterone Antagonist Eplerenone in Children with Hypertension: A Randomized, Double-Blind, Dose-Response Study
2010
Novel pharmacological treatments for heart failure
2003
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
2016
Diastolic Heart Failure in the Elderly
2007
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
2019
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Inflammation in Hypertension
2020
Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men’s Issue?
2019
Diastolic Heart Failure in the Elderly
2007
Physiology of Local Renin-Angiotensin Systems
2006 Standout
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
The RAAS in the pathogenesis and treatment of diabetic nephropathy
2010
Low-dose spironolactone in the management of resistant hypertension: a surveillance study
2007
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
The effect of RAAS blockade on the progression of diabetic nephropathy
2013
Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials
2008
Aldosterone and end-organ damage
2005
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Novel therapies blocking the renin–angiotensin–aldosterone system in the management of hypertension and related disorders
2006
Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis
2016 Standout
Detection, evaluation, and treatment of severe and resistant hypertension
2014
Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial
2014
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
2015
Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism
2007
Racial Differences in Sensitivity of Blood Pressure to Aldosterone
2014
Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension
2008
Arterial Stiffness and Cardiovascular Events
2010 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Systematic Review: Antihypertensive Drug Therapy in Black Patients
2004
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Synthesis, Biological Evaluation, and Molecular Modeling of 1-Benzyl-1H-imidazoles as Selective Inhibitors of Aldosterone Synthase (CYP11B2)
2010
Guidelines for the Primary Prevention of Stroke
2014 Standout
Improvement in Blood Pressure With Inhibition of the Epithelial Sodium Channel in Blacks With Hypertension
2005
Long-term ingestion of Hibiscus sabdariffa calyx extract enhances myocardial capillarization in the spontaneously hypertensive rat
2012
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Reconsidering the Roles of the Mineralocorticoid Receptor
2009
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Mechanisms of Diabetic Complications
2013 Standout
Eplerenone
2003
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Management of High Blood Pressure in Blacks
2010
Causes and Consequences of Increased Sympathetic Activity in Renal Disease
2004
Minireview: Primary Aldosteronism—Changing Concepts in Diagnosis and Treatment
2003
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
2020
Aldosterone and end-organ damage
2007
2007 ESH‐ESC Guidelines for the management of arterial hypertension
2007
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Primary aldosteronism: diagnostic and treatment strategies
2006
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Scott Krause being referenced
Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension
2003
Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension
2004
Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension
2003
Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
2006
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
2002
Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients
2003
Can Renin Status Predict the Antihypertensive Efficacy of Eplerenone Add‐On Therapy?
2003
Effects of eplerenone versus losartan in patients with low-renin hypertension
2005
Eplerenone reduces proteinuria in type II diabetes mellitus: implications for aldosterone involvement in the pathogenesis of renal dysfunction
2002
Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular Hypertrophy
2003
Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension
2003
Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients
2002